Authored By: Sarah
11 Jul 2024

 Sleep Apnea Implants Market Size to grow by USD 401.75 thousand between 2024-2028

According to a research report “ Sleep Apnea Implants Market” by Indication (Central sleep apnea, Obstructive sleep apnea) End-user (Ambulatory surgical centers, Hospitals, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 401.75 thousand, at a CAGR of  15.2% during the forecast period. The global sleep apnea implants market is projected to experience significant growth due to the rising incidence of sleep apnea and respiratory disorders worldwide. Sleep apnea is characterized by the interruption of normal breathing during sleep, which can be caused by obstruction in the upper airway or failure of the brain to send proper signals to breathe. Untreated sleep apnea can lead to severe health complications, including heart disease, diabetes, glaucoma, cancer, and cognitive and behavioral disorders. According to the Sleep Foundation, approximately one-third of US adults fail to obtain the recommended 7 hours of sleep per night, increasing the likelihood of developing sleep apnea and related conditions. This unmet need for effective treatment solutions presents a substantial opportunity for market growth.

Browse market data tables, figures, and in-depth TOC on “Sleep Apnea Implants Market” by Indication (Central sleep apnea, Obstructive sleep apnea) End-user (Ambulatory surgical centers, Hospitals, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Indication, the Central sleep apnea segment is projected to dominate the market size in 2024

The Ambulatory Surgery Centers (ASC) segment in the healthcare industry is experiencing robust growth due to its advantages over traditional hospitals. ASCs offer state-of-the-art surgical equipment, specialized surgeons, and well-appointed operating and recovery rooms, all without the intricacies of hospital administrative procedures. The cost savings associated with ASCs make them an attractive option for patients undergoing sleep apnea implant surgery. This trend is projected to continue, fueling the demand for sleep apnea implants in ASCs. Furthermore, many ASCs are affiliated with Group Purchasing Organizations (GPOs), enabling them to procure medical devices, including sleep apnea implants, at reduced costs. Consequently, the expanding ASC network and the cost savings they offer are significant growth drivers for the sleep apnea implant market.

By End-user, Ambulatory surgical centers  segment is expected to hold the largest market size for the year 2024

Central sleep apnea, a condition characterized by the brain's inability to send proper signals to respiratory muscles during sleep, can result in severe health complications, including heart disease, diabetes, glaucoma, cancer, and cognitive and behavioral disorders. The increasing recognition and diagnosis of this condition are driving demand for effective treatment alternatives. Sleep apnea implants have emerged as a leading solution for patients who struggle with or cannot tolerate traditional therapies, such as continuous positive airway pressure machines. These advanced devices, which are specifically designed to address central sleep apnea, offer a promising treatment option for those seeking relief from the potentially debilitating effects of this condition.

North America is forecasted to hold the largest market size by region in 2024

The Sleep Apnea Implants Market represents a significant business opportunity for medical device manufacturers. This market is driven by the increasing prevalence of sleep apnea and the growing awareness of its health consequences. Sleep apnea implants offer a minimally invasive solution for obstructive sleep apnea patients, providing an attractive alternative to Continuous Positive Airway Pressure (CPAP) therapy. Market growth is further fueled by technological advancements and regulatory approvals.

The Sleep Apnea Implants Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Advanced Brain Monitoring Inc.
  • Asahi Kasei Corp.
  • Avery Biomedical Devices Inc.
  • Cleveland Medical Devices Inc.
  • Contec Medical Systems Co. Ltd.
  • DeVilbiss Healthcare GmbH
  • Fisher and Paykel Healthcare Corp. Ltd.
  • Inspire Medical Systems Inc.
  • Koninklijke Philips N.V.
  • Linguaflex Inc.
  • LivaNova PLC
  • Medtronic Plc
  • Nihon Kohden Corp.
  • Nox Medical
  • Nyxoah SA
  • ResMed Inc.
  • Siesta Medical Inc.
  • SomnoMed Ltd.
  • Somnowell Ltd.
  • Vyaire Medical Inc.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

Sleep apnea is a sleep breathing disorder characterized by interruptions in the natural breathing mechanism during sleep, leading to symptoms such as sleepiness, insomnia, jet lag, and disturbed sleep. This condition is often caused by obstructive sleep apnea, where the airway becomes irritated and narrowed, obstructing the flow of oxygen. The healthcare ecosystem offers various solutions for sleep apnea, including the Inspire Medical System, a implantable device that stimulates the muscles responsible for breathing during sleep. However, the use of sleep apnea implants comes with peri-operative complications and high costs, making it a challenging option for many patients. Stringent government regulations and health-related complications such as airway irritation and sleep deprivation disorders further add to the complexity of this treatment. Additionally, fatal accidents caused by sleep deprivation disorders highlight the importance of effective sleep apnea treatments. Despite these challenges, advancements in technology and the healthcare industry continue to drive innovation in the sleep apnea implants market.

Market Research Overview

Title: Sleep Apnea Implants Market: Development, Clinical Studies, and Technological Advancements Obstructive Sleep Apnea (OSA) is a chronic sleep disorder affecting the adult American population, characterized by disturbed sleep and health-related complications such as obesity, hypertension, stroke, and cardiovascular conditions. Sleep Apnea Implants, including hypoglossal neurostimulators and palatal implants, have emerged as promising solutions for OSA therapy. Development in this field is ongoing, with clinical studies investigating the efficacy of these implants in managing muscle activity in the upper respiratory tract. Inspire Therapy, a leading player in this market, uses a hypoglossal neurostimulator and a bone screw system to stimulate throat muscles, promoting natural breathing during sleep. Technological advancements, such as Phrenic nerve stimulators and Signifier Medical Technologies' limb ischemia detection system, are also transforming OSA therapy. However, high costs, peri-operative complications, and stringent government regulations pose challenges to the market. OSA therapy includes various treatments, from sleep hygiene and wearables to sleep apnea devices and surgery. During Sleep Awareness Week, it's essential to raise awareness about the importance of early diagnosis and the role of medical practices, care centers, hospitals, and the medical device industry in providing effective treatments. Symptoms of sleep apnea, such as snoring, sleepiness, and disturbed sleep, can lead to fatal accidents due to sleep deprivation disorders. Conditions like obesity, diabetes, depression, and insomnia can worsen OSA severity. Ongoing clinical trials and research aim to improve the diagnosis rate and expand the scope of OSA therapy.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio